Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care

2518 - Perceptions of Clinical Trial Enrollment in Patients with Bone and Soft Tissue Sarcoma

Date

22 Oct 2018

Session

Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care

Topics

Patient Education and Advocacy

Tumour Site

Soft Tissue Sarcomas

Presenters

Ari Rosenberg

Citation

Annals of Oncology (2018) 29 (suppl_8): viii576-viii595. 10.1093/annonc/mdy299

Authors

A. Rosenberg1, S. Kircher2, E. Hahn3, A. Rademaker4, K. Bilimoria5, J.D. Wayne5, M. Agulnik2

Author affiliations

  • 1 Hematology/ Oncology, Northwestern University, 60611 - Chicago/US
  • 2 Hematology/ Oncology, Northwestern University, Chicago/US
  • 3 Medical Social Sciences, Northwestern University, Chicago/US
  • 4 Preventive Medicine, Northwestern University, Chicago/US
  • 5 Surgery, Northwestern University, Chicago/US
More

Resources

Abstract 2518

Background

Clinical trials represent a critical component in developing effective cancer therapies. Low rates of participation have negatively impacted progress in sarcoma trials. This survey study evaluated patients’ attitudes, knowledge, self-efficacy for decision-making, receptivity, general willingness to participate in trials, and perceptions related to molecular profiling (MP) of tumors.

Methods

IRB approval was obtained. Patients with sarcoma who were evaluated at an academic medical center between 2007 and 2017 were identified through the Enterprise Data Warehouse. A link to an online self-administered survey was emailed to patients. Data were analyzed using Spearman correlations and the Mann-Whitney test.

Results

Surveys were emailed to 750 patients of which 311 patients opened and 206 patients completed a portion of the survey (27.5% of total and 66.2% of opened surveys). Of the 206 patients, median age was 52 years, 57.8% were female, and 24.8% reported metastatic disease. Greater knowledge of trials correlated with increased positive attitudes toward trial participation (p < 0.001) and positive attitudes correlated with greater trial self-efficacy (p < 0.001). Patients with metastatic disease had more positive attitudes compared with nonmetastatic (p = 0.033). Trial enrollment was associated with greater knowledge (p = 0.002) and positive attitudes (p < 0.001). Among patients who reported knowledge of tumor MP (n = 46), 30.4% credit MP with a > 50% chance of isolating a targetable result, and 71.7% assume if an experimental treatment was found based on these results, there is a > 50% likelihood of it being effective. Better attitudes and higher self-efficacy were associated with expectations of lower likelihood of developing side effects from an experimental therapy (p = 0.0096; p = 0.0184). Of patients who had MP performed (n = 18), the most important consideration for this test was its ability to improve their survival and quality of life.

Conclusions

Improving knowledge of trials among sarcoma patients may lead to more positive attitudes and greater self-efficacy regarding trial enrollment. Sarcoma patients tend to overestimate the potential benefit of MP; thus, setting expectations with regards to potential benefit of MP is critically important.

Clinical trial identification

Legal entity responsible for the study

Northwestern University.

Funding

Northwestern University.

Editorial Acknowledgement

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.